The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Praxair's revenues will expand 2.2% and EPS will grow 2.9%.
The average estimate for revenue is $2.92 billion. On the bottom line, the average EPS estimate is $1.42.
Last quarter, Praxair reported revenue of $2.84 billion. GAAP reported sales were 5.1% higher than the prior-year quarter's $2.70 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $1.38. GAAP EPS of $1.38 for Q1 were 7.0% higher than the prior-year quarter's $1.29 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 43.1%, 10 basis points worse than the prior-year quarter. Operating margin was 22.0%, 10 basis points better than the prior-year quarter. Net margin was 14.8%, 10 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $11.73 billion. The average EPS estimate is $5.79.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 667 members out of 694 rating the stock outperform, and 27 members rating it underperform. Among 150 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 147 give Praxair a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Praxair is outperform, with an average price target of $116.00.
Can your retirement portfolio provide you with enough income to last? You'll need more than Praxair. Learn about crafting a smarter retirement plan in "The Shocking Can't-Miss Truth About Your Retirement." Click here for instant access to this free report.
- Add Praxair to My Watchlist.